Prilenia, Ferrer entered collaboration agreement for commercialization and co-development of pridopidine in Europe and other ...

Researchers found that inhibiting GSK-3 led to less defects in the axonal transport process and less neuronal cell death, while inhibiting ERK1 led to more transport problems and more cell death.

One protein mitigates Huntington’s disease while another one exacerbates it by regulating the huntingtin protein’s movement in neurons.

Ten years ago, researchers from the University at Buffalo provided some insight into a long-standing neuroscience conundrum: ...

The phase 2 PIVOT-HD trial of Novartis-partnered PTC518 (votoplam) showed that the oral mRNA splicing modifier was able to ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

University at Buffalo researchers shed some light on an enduring neuroscience mystery: How exactly does a mutated huntingtin protein (HTT) cause Huntington's disease?

PTC Therapeutics, Inc. (NASDAQ:PTCT) on Monday announced results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in ...

University at Buffalo researchers shed some light on an enduring neuroscience mystery: How exactly does a mutated huntingtin ...

While updated study results confirmed the drug lowers a target protein, the therapy's effect on clinical outcomes was less ...

University at Buffalo researchers shed some light on an enduring neuroscience mystery: How exactly does a mutated ...

Walks to bring awareness to a rare degenerative disease were held in five Iowa cities over the weekend. Huntington’s disease ...